they are recruiting again. Whoever thinks Roche's helping them with sales is clueless. Their sales staff have been come and go many times. They just can't sell the mammoth instruments to make enough commission.
the Roche deal and new units may pan out but IMO although the science is good these folks do not know how to run a company and their cost per unit is too high. with any luck for those still holding PACB they will get some people from Roche to HELP them run their company and give them guidance to profitability. the other major issue is their cash burn. the CEO is working for FREE through the end of 2013 and they've done how many offerings in the past year? my advise is to get out, average down, or be so patient you'll need to forget you own this.